Ebina, 1996 - Google Patents
Prophylaxis of rotavirus gastroenteritis using immunoglobulinEbina, 1996
- Document ID
- 18287062444330031170
- Author
- Ebina T
- Publication year
- Publication venue
- Viral Gastroenteritis
External Links
Snippet
Oral inoculation of the human group A rotavirus MO strain (G serotype 3) into 5-day-old BALB/c mice causes gastroenteritis characterized by diarrhea. Using this small animal model, passive protection of suckling mice against human rotavirus infection was achieved …
- 102000018358 Immunoglobulins 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ebina | Prophylaxis of rotavirus gastroenteritis using immunoglobulin | |
| Brüssow et al. | Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis | |
| Ebina et al. | Gastroenteritis in suckling mice caused by human rotavirus can be prevented with egg yolk immunoglobulin (IgY) and treated with a protein‐bound polysaccharide preparation (PSK) | |
| Kuroki et al. | Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk | |
| Korhonen et al. | Bovine milk antibodies for health | |
| Yolken et al. | Antibodies to rotaviruses in chickens' eggs: a potential source of antiviral immunoglobulins suitable for human consumption | |
| Ebina et al. | Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody | |
| Gadde et al. | Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases–a review | |
| US4341763A (en) | Methods of vaccinating humans against rotavirus infection | |
| Kuroki et al. | Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk | |
| Vega et al. | Egg yolk IgY antibodies: A therapeutic intervention against group A rotavirus in calves | |
| EP0990001B1 (en) | Processes for production of immunoglobulin a in milk | |
| US20250222101A1 (en) | Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine | |
| WO2008148149A1 (en) | Method of treatment or inhibition of enterovirus 71 infection | |
| JPH0657663B2 (en) | Method for producing multifunctional specific antibody | |
| CN112996808A (en) | Compositions and methods for treating acute diarrhea and intestinal infections in animals | |
| Amaral et al. | Anti-enteropathogenic Escherichia coli immunoglobulin Y isolated from eggs laid by immunised Leghorn chickens | |
| Castrucci et al. | The efficacy of colostrum from cows vaccinated with rotavirus in protecting calves to experimentally induced rotavirus infection | |
| JPH02160726A (en) | Vaccine | |
| Ylitalo et al. | Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis | |
| EP0930316B1 (en) | Oral product for the prevention and treatment of infectious gastroenteritides in calves | |
| Buragohain et al. | Evaluation of hyperimmune hen egg yolk derived anti-human rotavirus antibodies (anti-hrvigy) against rotavirus infection | |
| Lecce et al. | Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11 | |
| Snodgrass et al. | Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination | |
| Skrobarczyk et al. | Identification of 3 neutralizing linear epitopes on the VP8 outer capsid protein of group A equine rotavirus |